Steve Schonfeld’s AbbVie ABBV Stock Holding History

Steve Schonfeld’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,300	Closed	-$3.83M	–	1982
2025 Q1	$3.83M	Buy	+18,300	New	+$3.56M	0.02%	633

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steve Schonfeld's ABBV Position: Q2 2026 in Review

Steve Schonfeld increased its AbbVie (ABBV) stake by 97% in Q2 2026, buying an estimated $11M and bringing the position to 104,287 shares worth $26.2M. The position accounts for 0.09% of the portfolio, ranked #187.

Steve Schonfeld first reported a position in ABBV in Q3 2016 and has held it in 35 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Steve Schonfeld held 104,287 shares of AbbVie worth $26.2M as of Q2 2026.
Steve Schonfeld bought 51,227 AbbVie shares in Q2 2026, an estimated $11M.
AbbVie made up 0.09% of Steve Schonfeld's portfolio in Q2 2026, its #187 holding.
Steve Schonfeld first reported a position in AbbVie in Q3 2016 and has held it in 35 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.